Naoki Yamamoto¹, Yuki Matsumoto¹, Toshiyuki Takahashi², Kimihiko Kaneko¹, Shu Umezawa¹, Naoya Yamazaki¹, Naohiro Sakamoto¹, Chihiro Namatame¹, Hirohiko Ono¹, Yoshiki Takai¹, Hiroshi Kuroda^3,4, Kazuo Fujihara^3,4, Tatsuro Misu¹, Masashi Aoki¹ (1.Department of Neurology, Tohoku University Graduate School of Medicine, Japan, 2.Department of Neurology, National Hospital Organization Yonezawa National Hospital, Japan, 3.Multiple Sclerosis & neuromyelitis Optica Center, Japan, 4.Department of Multiple Sclerosis Therapeutics, Fukushima Medical University, Japan)

Akira Takekoshi¹, Akio Kimura¹, Yoya Ono¹, Nobuaki Yoshikura¹, Hiroaki Yaguchi², Ichiro Yabe², Takayoshi Shimohata¹ (1.Department of Neurology, Gifu University Graduate School of Medicine, Japan, 2.Department of Neurology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Japan)

Naoko Matsui¹, Keiko Tanaka^2,3, Osamu Watanabe⁴, Mitsuyo Ishida¹, Eiji Matsuura⁵, Hiroshi Takashima⁵, Yasunori Sato⁶, Satoshi Kuwabara⁷, Yuishin Izumi¹ (1.Department of Neurology, Tokushima University Graduate School of Biomedical Sciences, Japan, 2.Department of Animal Model Development, Brain Research Institute, Niigata University, Japan, 3.Department of Multiple Sclerosis Therapeutics, Fukushima Medical University, School of Medicine, Japan, 4.Department of Neurology, Kagoshima City Hospital, Japan, 5.Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Japan, 6.Department of Preventive Medicine and Public Health, School of Medicine, Keio University, Japan, 7.Department of Neurology, Graduate School of Medicine, Chiba University, Japan)

Shunsei Hirohata^1,2,4, Hirotoshi Kikuchi², Tetsuji Sawada³, Toshihiro Tono⁴, Izumi Kawachi^5,6 (1.Nobuhira Hospital, Japan, 2.Teikyo University School of Medicine, Japan, 3.Tokyo Medical University, Japan, 4.Kitasato University School of Medicine, Japan, 5.Niigata University School of Medicine, Japan, 6.Niigata University Brain Research Institute, Japan)